ISPOR Europe 2024
Barcelona, Spain
-
The ISPOR Europe 2024 conference, themed “Generating Evidence Toward Health and Well-Being,” took place from November 17 to 20 in Barcelona, Spain. The event highlighted the critical role of scientific evidence in understanding and enhancing global health and well-being. The program featured sessions on the science, practice, and policies of healthcare value assessment, emphasizing a holistic approach to health economics and outcomes research (HEOR)—one that integrates physical, mental, and social dimensions of healthcare innovation.
Posters
- Vittoria Ardito, Helen Banks, Rosanna Tarricone: Equity Implications of Including Environmental Impacts of Health Technologies in Economic Evaluations Informing Pricing and Reimbursement Decisions (EE164)
- Vittoria Ardito, James Robinson, Oriana Ciani: Does HTA Undermine the Goals of EMA Authorization Pathways? Time to Availability of Drugs Licensed Under Conditional Marketing Authorization Compared to Standard Marketing Authorization (HPR99)
Moderated Session
Title: Innovative Pricing and Payment Schemes for Health Technologies: Fine in Theory, but How to Make Them Work in Practice?
- Moderator: Oriana Ciani, PhD, CERGAS, SDA Bocconi School of Management, Milan, Italy
- Panelists:
- Mikel Berdud, PhD, Economics of Innovation, Office of Health Economics, London, UK
- Laura Sampietro-Colom, MD, PhD, Innovation Assessment Unit, Clinic Barcelona University Hospital, Barcelona, Spain
- Maria Cavaller Bellaubi, PharmD, EURORDIS, Barcelona, Spain